Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
3
43%
Ph phase_1
2
29%
Ph not_applicable
1
14%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Other(3)

Detailed Status

Completed3
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 33 (50.0%)
N/A1 (16.7%)

Trials by Status

active_not_recruiting114%
completed343%
unknown343%

Recent Activity

1 active trials
Showing 5 of 7
completedphase_1

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

NCT01497184
active_not_recruiting

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

NCT02520908
completedphase_3

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

NCT03416179
unknownphase_3

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

NCT03846362
unknownphase_1

Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia

NCT05576181
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01497184Phase 1

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Completed
NCT02520908

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

Active Not Recruiting
NCT03416179Phase 3

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Completed
NCT03846362Phase 3

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Unknown
NCT05576181Phase 1

Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia

Unknown
NCT01071226Not Applicable

Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device

Completed
NCT02059720Phase 3

Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

Unknown

All 7 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
7